Sun Pharma sells subsidiary in Japan to Zaza Industrial Holdings KK, ceasing operations with turnover less than 0.5%.

Senores Pharma shares listed at Rs 593.70 apiece on the BSE, reflecting a premium of 51.84 per cent over the IPO allotment ...

India’s revised Schedule M norms for pharmaceutical manufacturing, effective January 1, require compliance with stricter ...

WinTrust Pharmaceuticals Ltd. Top Ayurvedic Medicine Manufacturer in India has earned its reputation as a trusted name in the ...

Citius Pharma ( (CTXR) ) has released its Q4 earnings. Here is a breakdown of the information Citius Pharma presented to its investors. Citius Pharmaceuticals, Inc. is a biopharmaceutical company ...

The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, ...

TAS-0728 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Endometrial Cancer.

Shares of Senores Pharmaceuticals are scheduled to be listed on the stock exchanges today on Monday, December 30, following a ...

TAS-1440 is under clinical development by Taiho Pharmaceutical and currently in Phase I for Refractory Acute Myeloid Leukemia.

Domestic brokerage Motilal Oswal has recommended Mankind Pharma, Lupin, Max Healthcare, IPCA Laboratories, and Piramal Pharma ...

Sun Pharma stated that it has entered into an agreement with Zaza Industrial Holdings K.K., Japan, to sell 100% of its shares ...

New digital products always rely on early adopters to ... This new information can help pharma increase adherence by improving the quality of treatment and creating patient-centred programs ...